New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
06:45 EDTDGX, SQNMSequenom upgraded to Outperform from Market Perform at William Blair
William Blair upgraded Sequenom (SQNM) to Outperform after its survey indicated a high likelihood of non-invasive prenatal testing moving quickly into the $1B-plus average-risk pregnancy market. The firm also believes Sequenom's agreement last week with Quest Diagnostics (DGX) provides added market coverage.
News For SQNM;DGX From The Last 14 Days
Check below for free stories on SQNM;DGX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 24, 2014
21:54 EDTSQNMPiper Jaffray to hold a bus tour
Subscribe for More Information
August 19, 2014
11:32 EDTSQNMLabCorp prenatal test a negative for Sequenom, says Maxim
Maxim views LabCorp's (LH) announcement today that it will begin offering the informaSeq prenatal test as a long-term negative for Sequenom (SQNM) due to increased competition. The news is also negative for Illumina (ILMN) and PerkinElmer (PKI), who both offer Non-Invasive Prenatal Tests, Maxim adds. The firm recommends buying shares of LabCorp and keeps a Buy rating on the name with a $130 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use